Cost to Medicare of acute kidney injury in percutaneous coronary intervention
Authors' conclusion
AKI, and specifically CI-AKI, during PCI is associated with significantly longer PCI admission LOS, PCI admission costs, and long-terms costs.
Study context
- Population
- Medicare fee-for-service patients undergoing inpatient percutaneous coronary intervention (PCI), January 2017–June 2020
- Participants
- 509,039 patients
- Exposure
- Acute kidney injury (AKI) vs no AKI during PCI admission
- AKIn = 104,033
- Contrast-induced AKI (CI-AKI)n = 9,691
- Outcome
- PCI admission LOS and cost (Medicare paid amount, 2022 US$), and total costs
- Follow-up
- 1 year after PCI (total costs)
Methodological detailspropensity-matched analyses, Medicare 100% fee-for-service data
- Propensity-matched analyses
- Medicare 100% fee-for-service data
Main finding
As reported in the abstract
- AKI · index PCI admission length of stay (LOS)
- difference +4.12 days (95% CI 4.10–4.15)
- AKI · index admission costs
- difference +$11,313 (95% CI $11,093, $11,534)
- AKI · total 1-year costs
- difference +$14,800 (95% CI $14,359, $15,241)
- CI-AKI · LOS
- difference +3.03 days (95% CI 2.97–3.08)
- CI-AKI · index admission costs
- difference +$6,566 (95% CI $6,148, $6,984)
- CI-AKI · cumulative 1-year costs
- difference +$13,381 (95% CI $12,118, $14,644)
Observational data: associations, not effects.
Further findings
Propensity-matched analyses
- Results similar to full cohort
Original publication
Cost to Medicare of acute kidney injury in percutaneous coronary intervention. Am Heart J. Published 2 April 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →